Literature DB >> 12479710

Adenocarcinoma of the pancreas: CT imaging.

Karen M Horton1, Elliot K Fishman.   

Abstract

CT currently plays a vital role in pancreatic cancer staging. Continued advancements in computers, scanner technology, and 3D software have improved CT detection of smaller masses and staging. In particular, the introduction of MDCT and real-time 3D volume-rendering software have greatly improved the visualization of the pancreas and adjacent vasculature. This progress will continue as manufacturers introduce the next generation of scanners, which can acquire up to 32 slices per second with ever faster scan times. The impact of these new scanners on diagnostic accuracy will need to be carefully evaluated.

Entities:  

Mesh:

Year:  2002        PMID: 12479710     DOI: 10.1016/s0033-8389(02)00041-6

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  16 in total

1.  Pancreatic adenocarcinoma.

Authors:  Margaret A Tempero; J Pablo Arnoletti; Stephen Behrman; Edgar Ben-Josef; Al B Benson; Jordan D Berlin; John L Cameron; Ephraim S Casper; Steven J Cohen; Michelle Duff; Joshua D I Ellenhorn; William G Hawkins; John P Hoffman; Boris W Kuvshinoff; Mokenge P Malafa; Peter Muscarella; Eric K Nakakura; Aaron R Sasson; Sarah P Thayer; Douglas S Tyler; Robert S Warren; Samuel Whiting; Christopher Willett; Robert A Wolff
Journal:  J Natl Compr Canc Netw       Date:  2010-09       Impact factor: 11.908

Review 2.  Diagnostic evaluation of solid pancreatic masses.

Authors:  Jeffrey L Tokar; Rohit Walia
Journal:  Curr Gastroenterol Rep       Date:  2013-10

Review 3.  Borderline resectable pancreatic cancer.

Authors:  Bhargava Mullapudi; Patrick J Hawkes; Asish Patel; Chandrakanth Are; Subhasis Misra
Journal:  Indian J Surg Oncol       Date:  2015-01-04

4.  Pancreas-protocol imaging at a high-volume center leads to improved preoperative staging of pancreatic ductal adenocarcinoma.

Authors:  Dustin M Walters; Damien J Lapar; Eduard E de Lange; Marc Sarti; Jayme B Stokes; Reid B Adams; Todd W Bauer
Journal:  Ann Surg Oncol       Date:  2011-04-12       Impact factor: 5.344

5.  Diagnosis, Preoperative Evaluation, and Assessment of Resectability of Pancreatic and Periampullary Cancer.

Authors:  Ashish Verma; Sunit Shukla; Nimisha Verma
Journal:  Indian J Surg       Date:  2015-10-08       Impact factor: 0.656

6.  Impact of the time interval between MDCT imaging and surgery on the accuracy of identifying metastatic disease in patients with pancreatic cancer.

Authors:  Siva P Raman; Sushanth Reddy; Matthew J Weiss; Lindsey L Manos; John L Cameron; Lei Zheng; Joseph M Herman; Ralph H Hruban; Elliot K Fishman; Christopher L Wolfgang
Journal:  AJR Am J Roentgenol       Date:  2015-01       Impact factor: 3.959

7.  Role of multislice computed tomography in the diagnosis of gene-mutation-associated pancreatitis (GMAP).

Authors:  R Graziani; R Manfredi; C Cicero; A Contro; A Brandalise; M Tapparelli; L Frulloni; I Vantini; A Megibow; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2010-03-12       Impact factor: 3.469

8.  Pancreatic adenocarcinoma in a patient with situs inversus: a case report of this rare coincidence.

Authors:  Eric L Sceusi; Curtis J Wray
Journal:  World J Surg Oncol       Date:  2009-12-18       Impact factor: 2.754

9.  Pancreatic cancer--low survival rates.

Authors:  Hans G Beger; Bettina Rau; Frank Gansauge; Gerd Leder; Michael Schwarz; Bertram Poch
Journal:  Dtsch Arztebl Int       Date:  2008-04-04       Impact factor: 5.594

Review 10.  Therapeutic options for the management of pancreatic cancer.

Authors:  Maria L Rossi; Azeem A Rehman; Christopher S Gondi
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.